Kidney cancer

October 13, 2022
Dr. O'Dwyer and Dr. Schnall
October 13, 2022
Categories

From the Co-Chairs, October 2022

Research results in breast and kidney cancer; recognition of key colleagues; and a sneak peek of the Fall 2022 Group Meeting
Do you like it?
0 Read more
October 13, 2022
Couple speaking to doctor
October 13, 2022
Categories

Trial Results: ECOG-ACRIN Completes the First Randomized Phase 3 Clinical Trial of Neoadjuvant Immunotherapy in Patients with Kidney Cancer

The phase III PROSPER RCC clinical trial demonstrated that priming the immune system with nivolumab before surgery, then continuing nivolumab, did not improve recurrence-free survival in patients with high-risk renal cell carcinoma
Do you like it?
0 Read more